Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KNSA |
---|---|---|
09:32 ET | 2254 | 24.44 |
09:34 ET | 200 | 24.245 |
09:36 ET | 100 | 24.21 |
09:39 ET | 100 | 24.28 |
09:43 ET | 400 | 24.29 |
09:45 ET | 300 | 24.18 |
09:52 ET | 1715 | 24.25 |
09:54 ET | 200 | 24.1 |
09:56 ET | 897 | 24.06 |
09:59 ET | 6340 | 24.07 |
10:01 ET | 700 | 24.16 |
10:08 ET | 100 | 24.13 |
10:12 ET | 100 | 24.09 |
10:17 ET | 800 | 24.06 |
10:19 ET | 100 | 24.11 |
10:21 ET | 100 | 24.06 |
10:24 ET | 1600 | 23.98 |
10:26 ET | 500 | 23.98 |
10:28 ET | 100 | 23.965 |
10:33 ET | 815 | 23.98 |
10:35 ET | 2330 | 24.04 |
10:37 ET | 757 | 24.04 |
10:42 ET | 400 | 23.99 |
10:44 ET | 200 | 23.97 |
10:46 ET | 483 | 24.01 |
10:48 ET | 100 | 24.02 |
10:50 ET | 425 | 23.98 |
10:53 ET | 100 | 23.97 |
10:55 ET | 100 | 23.975 |
10:57 ET | 800 | 23.85 |
11:00 ET | 7217 | 23.662 |
11:02 ET | 192 | 23.71 |
11:04 ET | 300 | 23.74 |
11:06 ET | 364 | 23.7265 |
11:08 ET | 1014 | 23.807 |
11:09 ET | 1200 | 23.815 |
11:15 ET | 200 | 23.89 |
11:18 ET | 328 | 23.86 |
11:20 ET | 700 | 23.9 |
11:22 ET | 200 | 23.94 |
11:24 ET | 206 | 23.9 |
11:26 ET | 2891 | 23.96 |
11:27 ET | 641 | 24 |
11:29 ET | 1700 | 23.915 |
11:31 ET | 400 | 23.99 |
11:38 ET | 2791 | 23.995 |
11:40 ET | 300 | 24.06 |
11:42 ET | 4305 | 24.1 |
11:45 ET | 800 | 24.12 |
11:47 ET | 6902 | 24.24 |
11:49 ET | 200 | 24.24 |
11:54 ET | 100 | 24.24 |
11:56 ET | 600 | 24.29 |
11:58 ET | 400 | 24.29 |
12:00 ET | 1007 | 24.27 |
12:05 ET | 200 | 24.32 |
12:07 ET | 3400 | 24.24 |
12:09 ET | 600 | 24.26 |
12:12 ET | 351 | 24.225 |
12:14 ET | 1200 | 24.15 |
12:16 ET | 1100 | 24.06 |
12:18 ET | 500 | 24.1 |
12:23 ET | 700 | 24.1 |
12:25 ET | 948 | 24.1 |
12:32 ET | 900 | 24.065 |
12:36 ET | 736 | 24.07 |
12:39 ET | 200 | 24.105 |
12:41 ET | 545 | 24.1174 |
12:43 ET | 100 | 24.1 |
12:45 ET | 1000 | 24.05 |
12:48 ET | 300 | 24.08 |
12:52 ET | 400 | 24 |
12:56 ET | 225 | 23.96 |
12:59 ET | 767 | 23.967 |
01:01 ET | 300 | 23.94 |
01:03 ET | 500 | 23.97 |
01:08 ET | 100 | 23.985 |
01:10 ET | 100 | 24.01 |
01:12 ET | 100 | 23.985 |
01:15 ET | 1011 | 23.94 |
01:17 ET | 200 | 23.89 |
01:21 ET | 100 | 23.85 |
01:24 ET | 100 | 23.88 |
01:26 ET | 100 | 23.84 |
01:28 ET | 400 | 23.82 |
01:30 ET | 100 | 23.82 |
01:32 ET | 300 | 23.85 |
01:35 ET | 200 | 23.83 |
01:37 ET | 100 | 23.82 |
01:39 ET | 100 | 23.82 |
01:42 ET | 100 | 23.8 |
01:44 ET | 224 | 23.79 |
01:46 ET | 200 | 23.78 |
01:48 ET | 900 | 23.83 |
01:50 ET | 300 | 23.82 |
01:51 ET | 200 | 23.82 |
01:53 ET | 600 | 23.79 |
01:55 ET | 400 | 23.79 |
01:57 ET | 1100 | 23.84 |
02:04 ET | 200 | 23.84 |
02:06 ET | 200 | 23.82 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.7B | -133.2x | --- |
CareDx Inc | 1.5B | -9.8x | --- |
Zai Lab Ltd | 2.0B | -7.1x | --- |
Maravai LifeSciences Holdings Inc | 2.0B | -8.4x | --- |
MannKind Corp | 1.8B | 174.4x | --- |
BioCryst Pharmaceuticals Inc | 1.6B | -10.4x | --- |
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
---|---|
Revenue (TTM) | $338.9M |
Shares Outstanding | 71.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.32 |
EPS | $-0.18 |
Book Value | $6.23 |
P/E Ratio | -133.2x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -8.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.